Skip to main content

Table 1 Characteristics of the included CPGs

From: Quality assessment of evidence-based clinical practice guidelines for the management of pregnant women with sickle cell disease using the AGREE II instrument: a systematic review

Title Year of publication Country Level of development Organization (short name) Total number of references
ACOG Practice Bulletin Clinical Management Guidelines for Obstetrician-Gynecologists,
Number 78, January 2007 Hemoglobinopathies in Pregnancy [22]
(Reaffirmed 2018)
United States National American College of Obstetricians and Gynecologists (ACOG) 26 (one NCSR)
Sickle cell disease: managing acute painful episodes in the hospital. NICE Clinical guideline 143 [23] 2012
(minor update in 2016)
United Kingdom National National Institute of Health and Care Excellence (NICE) 97 (one NCSR) (reviewed and excluded NCSR and CSRs were not counted)
Management of Sickle Cell Disease in Pregnancy (Green-top Guideline No. 61). Royal College of Obstetricians and Gynaecologists [24] 2011 (updated 2018) United Kingdom National Royal College of Obstetricians and Gynaecologists (RCOG) 80 (one NCSR, 5 CSR)
Evidence-Based Management of Sickle Cell Disease: Expert Panel Report (EPR), 2014 [25] 2014
United States National US Department of Health and Human Services, National Institutes of Health, National Heart, Lung, and Blood Institute (NHLBI) 428 (5 NCSR, one CSR)
  1. Abbreviations: CPG clinical practice guideline; CSR Cochrane systematic review; NCSR Non-Cochrane systematic review